SpeedWeed

MAY 15, 2021

A first-of-its-kind Phase 3 clinical trial has found that MDMA-assisted therapy provided meaningful relief from PTSD symptoms in nearly 90 percent of study participants. For 88% of people who receive this treatment, we can expect to see a treatment response. View original article. Image via.

Clinical Trials 52

Clinical Trials Therapy Treatment DEA 52

SpeedWeed

FEBRUARY 18, 2021

From a clinical perspective, we found that treatment with cannabis led to a significant reduction in the Lichtiger Disease Activity Index and improvement in major IBD-related clinical symptoms including abdominal pain and number of bowel movements per day,” the results from the study claimed regarding the findings. “We

Clinical Trials 52

Clinical Trials Treatment Data THC 52

Project CBD

FEBRUARY 27, 2023

In the absence of an answer — or a cure — treatment is the name of the game for fibromyalgia. “Available data strongly support the use of cannabinoids in treating fibromyalgia pain” due to “overwhelmingly positive treatment results.” It’s not a new idea. That seemed to make all the difference.

THC 144

THC CBD Clinical Trials Sleep 144

MMJ Recs

JULY 30, 2024

This has spurred interest in alternative treatments like treating PTSD with cannabis, which interacts with the body’s endocannabinoid system, implicated in stress regulation and emotional processing. However, these treatments do not work for everyone and may come with side effects or limited efficacy in managing symptoms long-term.

Therapy 116

Therapy Treatment Clinical Trials Sleep 116

The Cannigma

JANUARY 24, 2021

This article was first published on Analytical Cannabis. The team at the University of Queensland soon noticed that one form of CBD was particularly adept at breaking down MRSA’s biofilms, the slimy structural supports that help the bacteria survive antibiotic treatments. It appears here with permission.

CBD 140

CBD Clinical Trials Treatment Pharmaceutical 140

Cannabis Law Report

DECEMBER 27, 2019

Virtual Clinical Trials transcend geographic, mobility and economic barriers. Clinical trials are medical research projects involving human participants. However, the costs of conducting a full-scale clinical trial can be prohibitive, posing barriers to research for cannabis companies.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

Cannabis Law Report

AUGUST 10, 2021

As psychedelic therapy trials approach FDA approval, researchers express the urgent need to ensure effectiveness and accessibility to communities of color. For example, the Tuskegee Syphilis Study, wherein Black men were deceived regarding their diagnosis and deprived appropriate treatment over the course of decades.

Clinical Trials 105

Clinical Trials Research and Development Therapy Treatment 105

Project CBD

MARCH 21, 2023

All but two of the 45 respondents said they’d consider cannabis as a treatment, with 29 seeking help for sleep disturbances, 27 for emotional complaints, 25 for functional disturbances, and nine for pain. Despite all this, there is a potential biological rationale for the treatment of tinnitus with cannabinoids, the authors explain.

Cannabinoids 144

Cannabinoids Clinical Trials Sleep Blood Pressure 144

Cannabis Law Report

JUNE 30, 2021

In addition, the company aims to predict what treatments are most effective in addressing these conditions, including psychedelics, which have shown tremendous promise in early clinical trials. The above article is sponsored content. MedXtractor Corp.’s of patients with major depressive disorder, 92.7% Looking Ahead.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

CannaMD

JUNE 2, 2021

Non-uses were also asked what factors might cause them to consider adding medical marijuana to their treatment regime. More than 80% of survey respondents indicated strong interest in learning more information about a clinical trial, and more than half were interested in enrolling in a clinical trial.

Patients 105

Patients Clinical Trials Treatment Research and Development 105

MMJ Recs

JULY 9, 2024

Traditional treatments, while helpful to some extent, often come with limitations and side effects that can further burden individuals already dealing with a debilitating disease. Medical marijuana has emerged as a promising alternative treatment option for managing symptoms associated with MS.

Marijuana 111

Marijuana Treatment Cannabinoids Patients 111

The Cannigma

FEBRUARY 2, 2021

This article was originally published on Analytical Cannabis and appears here with permission. . Of these consumers, over half said the drug had a beneficial clinical effect on their condition. Physicians should consider these aspects when advising their patients about treatment with medicinal cannabis.

Patients 98

Patients Clinical Trials Research and Development Treatment 98

Cannabis Law Report

AUGUST 5, 2021

Psychedelics are quickly emerging as alternative methods of treatment for mental illnesses and neurodegenerative conditions — particularly in countries such as Canada. FULL DISCLOSURE: This is a paid article produced by Stockhouse Publishing. per cent to reach US$6.86 billion in 2027, up significantly from $2.07 billion in 2019.

Extraction 105

Extraction Clinical Trials Research and Development Pharmaceutical 105

Cannabis Law Report

AUGUST 6, 2021

In this article, we’ll tell you what some of the top health benefits of CBD products are: Mental Health Disorders. It’s well known that CBD can be very useful in the treatment of mental health disorders, such as anxiety and depression. Clinical trials have shown that small doses of CBD help people to manage their social anxiety.

CBD 105

CBD Wellness and Beauty Treatment Pharmaceutical 105

Project CBD

NOVEMBER 11, 2023

And then cannabis has unique effects for a wide range of conditions, everything from the treatment of pain, treatment of asthma, treatment of immune conditions. We rate levels of evidence, and a high level may be a controlled randomized clinical trial (RCT), but there are also observational studies.

Medicine 306

Medicine Research and Development Pharmaceutical Cannabis 306

Cannabis Law Report

JUNE 19, 2022

For example, compounds such as psilocybin, mescaline, ibogaine, and LSD are being evaluated in clinical trials, but the compounds themselves are unpatentable because their existence is well documented in the prior art. However, that does not mean that the path to patents is closed off.

Clinical Trials 52

Clinical Trials Microdosing Data Pharmaceutical 52

SMPL

APRIL 27, 2020

Israeli scientists have launched clinical trials into whether cannabis can play an effective role in stopping or slowing the coronavirus. A second clinical trial will occur over the coming weeks and includes 10 Covid-19 patients currently undergoing treatment in Israel’s Rabin Medical Center.

Treatment 40

Treatment Clinical Trials CBD Patients 40

Cannabis Law Report

MARCH 23, 2022

Psychedelic medicine could provide much needed treatment options for some mental health and neurological disorders in the near future. There are a number of differences between PAP and current treatment approaches. The psychedelic renaissance is upon us! Secondly, people report being healed. of charge on the NHS.

Clinical Trials 52

Clinical Trials Treatment Medicine Access 52

Cannabis Law Report

OCTOBER 27, 2021

patent, but its first for a form of psilocybin the company isn’t using in its clinical trials on treatment-resistant depression. Read full article [link]. This is Compass Pathways’ fourth U.S. As always we’re expecting challenges,” said Compass’s co-founder and president Lars Christian Wilde. “We

Clinical Trials 52

Clinical Trials Medicine Treatment Law 52

Cannabis Law Report

AUGUST 7, 2022

In recent years, as more clinical trial results show that psychedelics can be used in conjunction with therapy to treat illnesses like depression and post-traumatic stress disorder, legislators pushed to make certain substances available in certain settings. But these substances remain illegal under federal law.

Law 74

Law Research and Development Therapy Treatment 74

Cannabis Law Report

JUNE 24, 2022

We have covered this but it is interesting to see theat the Guardian have picked up the story… All clinical trials into the psychoactive drug MDMA are being reviewed by Canadian regulators after complaints about abuse of study participants by a trailblazing American psychedelic research organization. Read the full article.

Clinical Trials 52

Clinical Trials Treatment Pharmaceutical Medicine 52

Cannabis Law Report

MAY 10, 2022

This is despite a limited number of high-quality clinical trials investigating the drug’s efficacy for this condition. Very few studies have also been done examining cannabis for the treatment of sleep disorders. Read their full article at . The findings were published today in Frontiers in Pharmacology.

Medicine 52

Medicine Clinical Trials Sleep Data 52

MMJ Recs

JULY 11, 2024

Medical marijuana is a potential treatment for insomnia, and it offers an alternative to traditional pharmaceuticals. In this article, we explore the role of medical marijuana in addressing insomnia, examining its effectiveness, safety considerations, legal aspects, and practical considerations for patients and healthcare providers.

Sleep 111

Sleep Treatment Research and Development Therapy 111

Cannabis Law Report

JULY 29, 2021

of their dry weight and it is not practical to obtain meaningful pure amounts of these compounds from the flesh of mushrooms, at a reasonable cost, to conduct clinical trials in humans and to commercialize these products. FDA approved guidelines for clinical studies. ” About Nova Mentis Life Science Corp.

Clinical Trials 105

Clinical Trials Conditions Packaging Events 105

MMJ Recs

NOVEMBER 20, 2023

This article delves into the science behind medical marijuana, focusing on cannabinoids, the active compounds found in the cannabis plant, and their remarkable therapeutic effects. Epilepsy Management: CBD, in particular, has emerged as an effective treatment for epilepsy, especially in individuals with rare and severe forms of the condition.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

Veriheal

MAY 3, 2022

Clinical Trial Sample Size. The trial was conducted with just 186 participants, which is far too small of a sample size to provide findings generalizable to the larger population. We’ll never know for certain whether this article was intentionally designed to scare potential MMJ patients away.

Research and Development 98

Research and Development Clinical Trials Consumption Patients 98

Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Available at: www.ncbi.nlm.nih.gov/pmc/articles/PMC7400098/.

CBD 144

CBD Seed-To-Sale Food Access 144

CannaMD

AUGUST 26, 2020

Current Cocaine Treatments. As researchers point out: There is no gold standard pharmacological treatment for dependence on cocaine. Although several drugs have been investigated, there is no strong or consistent evidence indicating any of these drugs for the treatment of cocaine use disorder. mice/rats). Hepatic protection.

Therapy 98

Therapy CBD Research and Development Treatment 98

Cannabis Law Report

OCTOBER 5, 2021

Systematic literature review of the therapeutic value, benefits and risks of MDMA and psilocybin for the treatment of mental health conditions. An evaluation of the therapeutic value, benefits and risks of methylenedioxymethamphetamine (MDMA) and psilocybin for the treatment of mental, behavioural or developmental disorders.

Treatment 52

Treatment Conditions Medicine Clinical Trials 52

Cannabis Law Report

MARCH 2, 2020

Food and Drug Administration (FDA) granted Breakthrough Therapy designation (BTD) to Compass Pathways ‘ psilocybin therapy for treatment-resistant depression. First up, cannabis has now been scientifically validated as a treatment for two severe forms of childhood epilepsy (more on this in a moment). In 2018, the U.S.

Medicine 59

Medicine Therapy DEA Pharmaceutical 59

United Patients Group

JANUARY 8, 2023

Cannabis has been shown to be an effective treatment for a variety of conditions caused by bacteria, viruses and fungi. The ECS may be involved in a number of other diseases and conditions, as well as cancer treatment side effects such as nausea or loss of appetite. Cannabis has Antiviral, Antibacterial and Fungal Properties.

Blood Pressure 122

Blood Pressure Sleep Cannabinoids Clinical Trials 122

Cannabis Law Report

JULY 9, 2021

Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. Since then, “ketamine clinics” have proliferated throughout the U.S., Id ; 21 CFR 312.1-10;

Law 81

Law Therapy Clinical Trials Research and Development 81

SpeedWeed

SEPTEMBER 17, 2021

The funding will allow MAPS Public Benefit Corporation (MAPS PBC) to activate a team to evaluate the scope of the lack of resources needed for TBI treatment. . Data collected from MAPS-sponsored Phase 3 clinical trials suggests that MDMA-assisted therapy appears promising in the treatment of TBI. View original article.

Clinical Trials 53

Clinical Trials Research and Development Therapy Treatment 53

MMJ Recs

DECEMBER 28, 2023

In recent years, a significant shift has occurred in the perception of medical marijuana, transforming it from a controversial substance to a recognized and, in some places, a legal form of medical treatment. Epidiolex, a CBD-based medication, has even received FDA approval for the treatment of specific seizure disorders.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

MMJ Recs

AUGUST 14, 2024

Traditional treatments, such as medications and physical therapy, usually fall short of providing effective relief. This article explores various aspects of using medical marijuana to alleviate neuropathic pain, offering tips and insights based on the latest medical research.

Nerve Pain 96

Nerve Pain Marijuana Strains Chronic Pain 96

Cannabis Law Report

MAY 31, 2022

In a previous article, we explored one potential current opportunity for entrepreneurs interested in psychedelics and mycelium— producing non-psychoactive mushroom supplements. Food and Drug Administration (FDA) approved esketamine (a component of Ketamine and sold under the brand name Spravato) for treatment-resistant depression.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

The Joint Blog

APRIL 21, 2020

This is according to a study published in the Journal of Clinical Medicine Research and epublished by the U.S. For the study researchers with the Nordic Cannabis Research Institute in Denmark reviewed 25 clinical trials assessing the safety and efficacy of CBD in various populations. National Institute of Health.

Clinical Trials 52

Clinical Trials CBD Safety Patients 52